Elevated B-Type Natriuretic Peptide Is Associated With Increased In-Hospital Mortality or Cardiac Arrest in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation
暂无分享,去创建一个
J. Curtis | Yongfei Wang | D. Marinac-Dabic | Kristi R Mitchell | M. Haigney | N. Loyo-Berrios | E. Pinnow | Hong Cheng | Shaokui Wei | Jim Beachy | A. Woodward | Kristi R. Mitchell
[1] B. Lindsay,et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. , 2009, Heart rhythm.
[2] P. Heidenreich,et al. Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy , 2009, Circulation.
[3] Peter Buser,et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. , 2009, JAMA.
[4] Karen A. Hartman,et al. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. , 2009, Clinical chemistry.
[5] J. Healey,et al. Complications associated with defibrillation threshold testing: the Canadian experience. , 2008, Heart rhythm.
[6] Chunliu Zhan,et al. Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis , 2007, Journal of General Internal Medicine.
[7] A. Maisel,et al. State-of-the-Art PaperNatriuretic Peptides , 2007 .
[8] S. Saba,et al. Effect of End‐Stage Renal Failure and Hemodialysis on Mortality Rates in Implantable Cardioverter‐Defibrillator Recipients , 2007, Pacing and clinical electrophysiology : PACE.
[9] B. Lindsay,et al. Review of the registry's first year, data collected, and future plans. , 2007, Heart rhythm.
[10] D. Cohen,et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.
[11] R. Brindis,et al. The National ICD Registry: now and into the future. , 2006, Heart rhythm.
[12] M. Chung,et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies , 2005, Heart.
[13] David M. Rocke,et al. Hierarchical Logistic Regression Modeling with SAS GLIMMIX , 2006 .
[14] L. Køber,et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.
[15] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[16] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[17] H. Huikuri,et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. , 2004, Journal of the American College of Cardiology.
[18] A. Kadish,et al. DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE). , 2003, Cardiac electrophysiology review.
[19] J. Hollander,et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] Pedro Lozano. Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.
[21] Douglas W Mahoney,et al. Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.
[22] R. Berger,et al. B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.
[23] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[24] A. Coats. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? , 2002, International journal of cardiology.
[25] J. Sanderson,et al. Plasma brain natriuretic peptide — an independent predictor of cardiovascular mortality in acute heart failure , 1999, European journal of heart failure.